Rua Bioscience Limited announced the renewal of its distribution agreement with Nimbus Health in Germany for a three-year term. Rua signed their first distribution agreement with Nimbus Health In Germany in April 2023. The German medical cannabis market is the largest and most developed in Europe.

Currently worth EUR 454 million, it's expected to be worth EUR 749 million by 2027. Regulatory changes that came into effect on 1st April 2024 are expected to significantly expand the market for medicinal cannabis products in Germany. To meet this ever-increasing demand, Rua is planning to launch new products in the coming months.

The continuation of the distribution agreement with Nimbus Health is a key pillar in Rua Bioscience's strategy of commercializing their unique genetics on a global scale.